Keybioscience A/s

Nordic Bioscience A/s

Keybioscience Ag

Morten Asser Karsdal

Nozer M Mehta

William Stern

Per Qvist

Amy M Sturmer

Kim Henriksen

Diana Julie Leeming

Claus Christiansen

Christina Jensen

Inger Byrjalsen

Ida Falk Villesen

Lasse Langholm

Emilie Albrecht Madsen

Mette Juul Fisker

Nicholas Willumsen

Diana Julie Oersnes Leeming

Joachim Hog Mortensen

Niels Ulrik Brandt Hansen

Jeppe Thorlacius-Ussing

Provided herein are methods for the treatment of type I diabetes, Type II diabetes, metabolic syndrome, or obesity, or of appetite suppression, or for mitigating insulin resistance, or for reducing an undesirably high fasting serum glucose level, or for reducing an undesirably high peak serum glucose level, or for reducing an undesirably high peak serum insulin level, or for reducing an undesirably large response to a glucose tolerance test in synergistic combination with metformin. Treatment is effected with a combination therapy of metformin and a peptide with a sequence selected from SEQ ID NO: 11, SEQ ID NO: 12, SEQ ID NO: 13, SEQ ID NO: 14, SEQ ID NO: 15, SEQ ID NO: 16, SEQ ID NO: 17, SEQ ID NO: 19, SEQ ID NO: 20, SEQ ID NO: 21, SEQ ID NO: 22, SEQ ID NO: 23, and SEQ ID NO: 24 administered to a patient.

Peptide analogs for treating diseases and disorders

Growing community of inventors

Kobenhavn, Denmark

Morten Asser Karsdal